Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key.

Thomas QD, Firmin N, Mbatchi L, Evrard A, Quantin X, Leenhardt F

DOI: 10.3390/ijms24065518
Published: 2023 Mar 14
Container: International journal of molecular sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ijms24065518,
  title = {Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key.},
  author = {Thomas QD and Firmin N and Mbatchi L and Evrard A and Quantin X and Leenhardt F},
  year = {2023},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms24065518},
  url = {https://doi.org/10.3390/ijms24065518}
}

RIS

TY  - JOUR
TI  - Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key.
AU  - Thomas QD
AU  - Firmin N
AU  - Mbatchi L
AU  - Evrard A
AU  - Quantin X
AU  - Leenhardt F
PY  - 2023
JO  - International journal of molecular sciences
DO  - 10.3390/ijms24065518
UR  - https://doi.org/10.3390/ijms24065518
ER  -

APA

QD, T., N, F., L, M., A, E., X, Q., & F, L. (2023). Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key.. International journal of molecular sciences. https://doi.org/10.3390/ijms24065518

Source records

pubmed · retrieved 2026-11-10T15:13:07.694Z